Highlights RxSight, Inc.

Equities

RXST

US78349D1072

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
57.22 ^USD	-2.54%		-2.14%	+41.91%

May. 21	Rxsight Insider Bought Shares Worth $305,457, According to a Recent SEC Filing	MT
May. 15	Transcript : RxSight, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 through May-16-2024

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RxSight Raises $115 Million From Public Offering of Shares	May. 13	MT
RxSight Q1 Adjusted Loss Narrows, Revenue Rises	May. 07	MT
Earnings Flash (RXST) RXSIGHT Posts Q1 Revenue $29.5M, vs. Street Est of $27.6M	May. 06	MT
RxSight, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 06	CI
RxSight, Inc. Increases Earnings Guidance for the Full Year 2024	May. 06	CI
RxSight Launches New Light Adjustable Lens Product	Apr. 04	MT
RxSight, Inc. Announces Commercial Launch of its Newest Light Adjustable Lens??, the LAL+??, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting	Apr. 04	CI
RxSight's Q4 Adjusted Loss Narrows, Sales Increase; Reiterates 2024 Revenue Guidance	Feb. 29	MT
Earnings Flash (RXST) RXSIGHT Reports Q4 Revenue $28.6M, vs. Street Est of $27.9M	Feb. 28	MT
Rxsight, Inc. Reiterates Earnings Guidance for the Full Year 2024	Feb. 28	CI
RxSight, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
RxSight, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28	CI
RxSight Says It Expects Q4 Revenue to Increase 78% Year on Year; Shares Jump	Jan. 08	MT
RxSightinc. Provides Earnings Guidance for Preliminary Unaudited Fourth Quarter 2023 , Preliminary Unaudited Fiscal Year 2023 and for Full-Year 2024	Jan. 07	CI
Earnings Flash (RXST) RXSIGHT Reports Q3 Revenue $22.2M, vs. Street Est of $20.6M	Nov. 09	MT
RxSight, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Rxsight, Inc. Raises Earnings Guidance for the Full Year of 2023	Nov. 09	CI
RxSight's Q2 Adjusted Loss Narrows, Revenue Rises	23-08-08	MT
RxSight, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07	CI
Earnings Flash (RXST) RXSIGHT Posts Q2 Revenue $20.8M, vs. Street Est of $19.2M	23-08-07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights RxSight, Inc.

Equities

RXST

US78349D1072

Highlights

Filters